Research Article
Real-World Experience with Cangrelor as Adjuvant to Percutaneous Coronary Intervention: A Single-Centre Observational Study
Table 4
Outcomes within 48 hours after cangrelor administration.
| All-cause death | 26 (2.6%) | BARC 5a | 1 (0.1%) | BARC 5b | 5 (0.5%) | Cardiac death | 18 (1.8%) | Death, other | 2 (0.2%) | Non-fatal bleeding more than BARC 2 | | BARC 3a | 11 (1.1%) | BARC 3b | 11 (1.1%) | BARC 3c | 1 (0.1%) | Acute myocardial infarction | 2 (0.2%) | Stent thrombosis | 2 (0.2%) | Ischemic stroke | 2 (0.2%) |
|
|
BARC: Bleeding Academic Research Consortium.
|